Skip to content
Wednesday 19 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,743.35
+0.14%
DAX
26,091.33
-0.14%
CAC 40
8,501.91
-0.09%
STOXX 50
6,444.46
-0.37%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 21 September 2020 11:39 am

UK on track for 200 Covid deaths a day based on current infection rate

By: Stefan Boscia

Add as a preferred source on Google
BRITAIN-HEALTH-VIRUS
A waitress wearing a protective face covering brings drinks to customers in the late summer sunshine at outside tables in Soho, central London on September 20, 2020 as the British government consider fresh nationwide restrictions after an rise in cases of the novel coronavirus. - The government this week tightened restrictions on socialising because of a surge in coronavirus cases, and imposed local lockdowns across swathes of the country. (Photo by DANIEL LEAL-OLIVAS / AFP) (Photo by DANIEL LEAL-OLIVAS/AFP via Getty Images)

The UK could be on track to have 200 Covid deaths a day by November if current rates of infection continue, according to the UK’s top scientific official.

Chief scientific adviser Sir Patrick Vallance said that coronavirus cases are currently doubling every seven days, while also revealing that only 8 per cent of Britons have any sort of immunity.

Vallance said in a live address that Covid cases are rising for all UK age groups, with 20 to 40 year olds seeing the largest increases.

The chief scientific adviser said this has led to an increasing number of hospitalisations.

He said that if the current trend continues that the UK will see 50,000 cases per day in a months’ time and 200 deaths a day a month after that.

“As the disease spreads, as it spreads across age groups, we expect to see increase in hospitalisations and unfortunately those increases will lead to an increase in deaths,” Vallance said.

It comes as health secretary Matt Hancock said yesterday that the country was at a “tipping point” and that new restrictions would be imposed if people did not follow the rules.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Chief medical officer professor Chris Whitty said that the country would have a “very serious problem” if “we do not change course”.

Whitty said that there needed to be a balance of considerations as a new lockdown would bring plunge an already ailing economy into a deeper recession.

However, the chief medical officer added that the virus would also likely spread faster as the year progresses.

“The seasons are against us,” he said.

“We’re now going into late autumn and winter, which benefit respiratory virus’ and its very likely they will benefit Covid as they do flu.

“We should see this as a six month problem.”

The pair also gave some more positive as news, as Vallance announced that there is a chance a vaccine could be available in small amounts by the end of the year.

He said that it looked like at least one of the ongoing trials would yield positive results, with the potential for a comprehensive vaccination programme by the first half of next year.

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Morning Wire Content
  • Politics

Trending Articles

  • Jobless Banquet: Youth unemployment surge ‘sends Neets to KFC’

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Amanda Blanc has worked her magic at Aviva

  • City law firm sues prominent Emirati business family

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Hargreaves Lansdown orders staff back to office

    Investing
    Hargreaves Lansdown financial services office exterior with company logo prominently displayed on modern building façade
  • We reached Mars 50 years ago, why haven’t we sent people?

    Opinion
    Mars One rocket on launchpad, ready for its mission to the red planet
  • Almirall H1 2026 Results

    Business Wire
  • TOURISE and Oxford Economics Release New Global Report on Tourism Resilience in an Era of Permanent Disruption

    Business Wire
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • Prothena to Report Second Quarter 2026 Financial Results on August 6

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook